Dickinson, ClareTayler, Liz2019-09-252019-09-252011-04-1820060745325092http://hdl.handle.net/20.500.12424/177805"While the corruption that affects HIV/AIDS prevention and treatment does not look very different from corruption found in other areas of the health sector, the scale of the pandemic, the stigma attached to the disease and the high costs of drugs to treat it magnify the problem. The response to HIV/AIDS must involve an increase in funds available to purchase drugs. But scaling up budgets without paying due regard to the anti-corruption mechanisms needed to ensure their proper use provides further opportunity for corruption. A case study from Kenya shows a worst-case scenario, of corruption and profligacy at the national AIDS body set up to coordinate prevention programmes. An examination of the Global Fund finds that including all stakeholders in the design of programmes, from governments and NGOs to the sufferers themselves, could help provide a safeguard against corruption."(pg 103)Pages: 12engWith permission of the license/copyright holderAIDS Acquired Immune Deficiency Syndromehealth ethicsBioethicsMedical ethicsHealth ethicsBook chapter